What is Guardant Health Price-to-Operating-Cash-Flow?
As of today (2024-04-25), Guardant Health's share price is $17.185.
Guardant Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.91. Hence, Guardant Health's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Guardant Health's Price-to-Operating-Cash-Flow or its related term are showing as below:
Guardant Health's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $-0.66.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.91.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -39.60% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -22.00% per year.
During the past 8 years, Guardant Health's highest 3-Year average Operating Cash Flow per Share Growth Rate was 4.60% per year. The lowest was -79.90% per year. And the median was -1.40% per year.
Guardant Health Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Guardant Health's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardant Health Price-to-Operating-Cash-Flow Chart
|
Guardant Health Annual Data
|
|
Trend |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
- |
- |
- |
- |
- |
|
Guardant Health Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Guardant Health's Price-to-Operating-Cash-Flow
For the Diagnostics & Research subindustry, Guardant Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardant Health's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Guardant Health's Price-to-Operating-Cash-Flow falls into.
Guardant Health Price-to-Operating-Cash-Flow Calculation
Guardant Health's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 17.185 | / | -2.914 |
| = | |
Guardant Health's Share Price of today is $17.185.
Guardant Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.91.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Guardant Health (Guardant Health) Business Description
Traded in Other Exchanges
Address
3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Executives
| Meghan V. Joyce |
director |
THE BOSTON BEER COMPANY, INC., ONE DESIGN CENTER PL., STE. 850, BOSTON MA 02210 |
| Kumud Kalia |
officer: Chief Information Officer |
505 PENOBSCOT DRIVE, REDWOOD CITY CA 94063 |
| Ines Dahne-steuber |
officer: Chief Operating Officer |
3100 HANOVER STREET, PALO ALTO CA 94304 |
| Darya Chudova |
officer: Chief Technology Officer |
3100 HANOVER STREET, PALO ALTO CA 94304 |
| Helmy Eltoukhy |
director, officer: Chief Executive Officer |
2 BARRY LANE, ATHERTON CA 94027 |
| Amirali Talasaz |
director, officer: Chairman, President and COO |
18 ISABELLA AVENUE, ATHERTON CA 94027 |
| Musa Tariq |
director |
3100 HANOVER STREET, PALO ALTO CA 94304 |
| Amelia Merrill |
officer: SVP, People |
505 PENOBSCOT DRIVE, REDWOOD CITY CA 94063 |
| Steve E. Krognes |
director |
863 MITTEN ROAD, SUITE 102, BURLINGAME CA 94010 |
| Stanley J Meresman |
director |
2071 HUNTINGTON LANE, LOS ALTOS CA 94024 |
| Myrtle S Potter |
director |
10 FINDERNE AVE, BRIDGEWATER NJ 08807 |
| Ian T Clark |
director |
SOLAZYME, INC., 225 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080 |
| Chris Freeman |
officer: Chief Commercial Officer |
505 PENOBSCOT DRIVE, REDWOOD CITY CA 94063 |
| Bahija Jallal |
director |
120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
| Vijaya Gadde |
director |
C/O TWITTER INC, 1355 MARKET STREET SUITE 900, SAN FRANCISCO CA 94103 |
Guardant Health (Guardant Health) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GH has been successfully added to your